RNeasy Mini Kit

High-quality total RNA in minutes.

Investigator 24plex QS Kit

Multiplex amplification for human ID, with CODIS and European standard markers.

QIAsphere

Monitor and manage your QIAsphere-ready instruments from anywhere, using any mobile device.

Smart ideas, deep insights

Get inspiring content today – with a free face mask.

QIAGEN Clinical Insight (QCI) Interpret

Transparent, evidence-based NGS interpretation and reporting.

Find out more

QIAGENbioinformatics.com

COVID-19 testing and research

Up to date protocols and list of COVID-19 testing and research solutions.

RNeasy Mini Kit

High-quality total RNA in minutes.

Smart ideas, deep insights

Get inspiring content today – with a free face mask.

QuantiFERON-TB Gold Plus

Detect TB infection with confidence.

QIAGEN Clinical Insight (QCI) Interpret

Transparent, evidence-based NGS interpretation and reporting.

Strategy

Home  >  Investor Relations  >  At a Glance  >  Strategy

Executing with focus and balance to build value through profitable growth opportunities

We are a global leader in Sample to Insight solutions, with a portfolio of technologies to empower customers from start to finish in the molecular analysis process. In a challenging world, our approach is to help customers achieve molecular insights faster, better and more efficiently.

Our strategy contains a focus on 5 Pillars of Growth where we have novel technologies targeting >$6 billion in opportunities out of our >$11 billion total addressable market. In these areas we are aligning our investments to maximize sales in proven high-growth markets. (See the Key product areas section on Our Products page for more details)

We focus on area to build and maintain leading positions

Our business is well-balanced across the globe (see Our global presence for more details) over two major customer classes. We have built a unique competitive advantage for QIAGEN: deep relationships with customers across the continuum from academic research, to pharmaceutical development, to molecular diagnostics and other applications. We partner with researchers in creating molecular testing technologies in the early stages, then develop and commercialize promising applications and platforms as these methods emerge in healthcare and industry.

Turning strategy into action